The Prognostic Impact of Soluble Apoptosis-Stimulating Fragment on Mortality in Patients With Carotid Atherosclerosis
Author(s) -
Matthias Hoke,
Martin Schillinger,
Gerlinde Zorn,
Anna Wonnerth,
Jasmin Amighi,
Wolfgang Mlekusch,
Walter S. Speidl,
Gerald Maurer,
Renate Koppensteiner,
Erich Minar,
Johann Wojta,
Alexander Niessner
Publication year - 2011
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.110.611301
Subject(s) - medicine , interquartile range , asymptomatic , hazard ratio , cause of death , cardiology , confounding , gastroenterology , stroke (engine) , c reactive protein , disease , inflammation , confidence interval , mechanical engineering , engineering
Markers of apoptosis are associated with cardiovascular disease. The soluble apoptosis-stimulating fragment (sFAS) was found to be a predictor for outcome in patients with heart failure, but its importance in patients with atherosclerotic disease has not been fully understood as yet. The aim of the present study was to investigate the impact of sFAS on all-cause and cardiovascular mortality in patients with atherosclerosis in the carotid arteries.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom